2010 annual financial data
Marker Therapeutics 2010 Operating margin
Marker Therapeutics 2010 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,941,511 USD and net income was -5,090,651 USD.
Operating cash flow was -925,041 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -3,941,511 USD
- Net income
- -5,090,651 USD
- Operating cash flow
- -925,041 USD